STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
Cision•20/08/2026•02:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.